Clinical Trial Update: Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Results from a Phase 2 trial of the panobinostat, bortezomib, and dexamethasone combination in relapsed or relapsed-and-refractory multiple myeloma have been co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Panobinostat (Panobinostat)

Snippet

Sponsor: pharmaand GmbH | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2024-07-12